ELANE and cancer: Recently, a research group found that the Kunitz-type protease inhibitor EgKI-1, a potent chymotrypsin and neutrophil elastase inhibitor highly expressed by oncosphere of E. granulosus (Ranasinghe et al., 2015), could inhibit several human cancers from growth and migration, probably through disrupting cell cycle and inducing apoptosis of cancer cells, without affecting normal cell growth in vitro (Ranasinghe et al., 2018).